Почетна › Sitnoćelijski rak pluća › Masachuset › Boston
Kliničke studije za Sitnoćelijski rak pluća u gradu Boston, MA
22 studija za Sitnoćelijski rak pluća traži učesnike na lokacijama u gradu Boston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
Тражи се учесникФаза 1/2
- Dana-Farber Cancer Institute, Boston
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- Dana Farber Cancer Institute, Boston
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Тражи се учесникФаза 2
- Dana-Farber Cancer Institute /ID# 277732, Boston
SMARCA4/2 Inhibitor for POU2F3-Positive SCLC
Тражи се учесникФаза 2
- Dana-Farber Cancer Institute, Boston
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Тражи се учесникОпсервациона студија
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- и још 1
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Тражи се учесникФаза 1/2
- Avenzo Therapeutics Recruiting Site, Boston
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Тражи се учесникФаза 2
- Massachusetts General Hospital (MGH), Boston
- Dana Farber Cancer Institute, Boston
DNA Analysis of Blood and Tissue From Patients With Lung Cancer
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Massachusetts General Hospital, Boston
- Harvard School of Public Health, Boston
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Тражи се учесникФаза 1/2
- Dana Farber Cancer Institute ( Site 1105), Boston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Тражи се учесникФаза 1/2
- Tufts Medical Center, Boston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Тражи се учесникФаза 3
- Dana-Farber Cancer Institute /ID# 279690, Boston
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Тражи се учесникФаза 1
- Massachusetts General Hospital, Boston
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Тражи се учесникФаза 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Dana Farber Cancer Institute, Boston
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Тражи се учесникФаза 2
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Massachusetts General Hospital Cancer Center, Boston
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Тражи се учесникФаза 3
- Dana-Farber Cancer Institute, Boston
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
Тражи се учесникФаза 1
- Massachusetts General Hospital, Boston
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- Beth Israel Deaconess Medical Center, Boston
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Тражи се учесникФаза 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Тражи се учесникФаза 2
- Tufts Medical Center, Boston
Studije za Sitnoćelijski rak pluća u drugim gradovima
- Houston, TX26 студија
- New York City, NY23 студија
- Arlington, VA22 студија
- Los Angeles, CA20 студија
- Nashville, TN20 студија
- Orlando, FL14 студија
- Chicago, IL13 студија
- Cleveland, OH13 студија
- Dallas, TX13 студија
- St. Louis, MO13 студија
- Washington, DC13 студија
- Detroit, MI12 студија
Ostale studije u gradu Boston
- Рак дојке110 студија
- Рак (све врсте)90 студија
- Немалоклетни карцином плућа87 студија
- Рак плућа63 студија
- Колоректални карцином62 студија
- Рак јајника62 студија
- Метастатски карцином61 студија
- Рак простате56 студија
- Карцином ендометријума51 студија
- Депресија50 студија
- Затајење срца46 студија
- Многи мијелом45 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.